Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?

World Journal of Surgery

Volumn 31, Issue 2, 2007, Pages 267-275

  Bembenek, A ^a   Fischer, J ^a   Albrecht, H ^a   Kemnitz, E ^a   Gretschel, S ^a   Schneider, U ^a   Dresel, S ^a   Schlag, P M ^a  

^a Section of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; BODY MASS; BREAST CANCER; CALCULATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; COLLOID; DISSECTION; FALSE NEGATIVE RESULT; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMATION PROCESSING; LABORATORY DIAGNOSIS; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; OBESITY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR GROWTH; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 33846598354     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0720-7     Document Type: Article

References (47)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
2. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349(6):546-553.
3. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227(5):645-653.
4. Schlag PM, Bembenek A.. Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer. Recent Results Cancer Res 2000;157:228-236.
5. Martin RCG, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery 2001;1281:39-144.
6. Lyman G, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.
7. Kuehn T, Bembenek A, Decker T, et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005;103(3):451-461.
8. Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2005;8(2):88-91.
9. Derossis AM, Fey JV, Cody HS, et al. Obesity influences outcome of sentinel lymph node biopsy in early breast cancer. J Am Coll Surg 2003;197:896-901.
10. Pelosi E, Ala A, Bellò M, et al. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer. Eur J Nucl Med Mol Imaging 2005;32(8):937-942.
11. Ozmen V, Muslumanoglu M, Cabioglu N, et al. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 2002;76:237-244.
12. Arican P, Ibis E, Aras G, et al. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m sulfur colloid. Clin Nucl Med 2005;30:317-321.
13. Meyer JS. Sentinel lymph node biopsy: Strategies for pathologic examination of the specimen. J Surg Oncol 1998;69:212-218.
14. Sobin LH, Wittekind C. (2002) TNM classification of malignant tumors Wiley-Liss, New York.
15. Agresti A. Categorical data analysis. New York, Wiley,1990.
16. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18(13):2560-2566.
17. Tanis PJ, Nieweg OE, Merkus JWS, et al. False negative sentinel node procedure established through palpation of the biopsy wound. Eur J Surg Oncol 2000;26:714-721.
18. Van der Ent FWC, Kengen RAM, van der Pol HAG, et al. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999;25:25-29.
19. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphscintigraphy and gamma probe detection. J Am Coll Surg 1998;186(3):275-283.
20. Leppänen E, Leidenius M, Krogerus L, et al. The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. Eur J Surg Oncol 2002;28:821-826.
21. Wong SL, Edwards MJ, Chao C, et al. The effect of lymphatic tumor burden on sentinel lymph node biopsy results. Breast J 2002;8(4):192-198.
22. Goyal A, Douglas-Jones AG, Newcombe RG, et al. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 2005;11(3):188-194.
23. Olson JA, Fey J, Winawer J, et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000;191(6):593-599.
24. Krag DN, Weaver DL, Ashikaga T, et al. The sentinel node in breast cancer. N Engl J Med 1998;339(14):941-946.
25. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18(13):2553-2559.
26. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
27. Bedrosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-2545.
28. Chung MH, Ye W, Giuliano AE.. Role of sentinel lymph node dissection in the management of large (>5 cm) invasive breast cancer. Ann Surg Oncol 2001;8(9):688-692.
29. Leidenius MHK, Krogerus LA, Toivonen TS, et al. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol 2005;31:364-368.
30. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233(1):51-59.
31. Wong SL, Chao C, Edwards MJ, et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg 2001;67:522-526.
32. Barone JE, Tucker JB, Perez JM, et al. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg 2005;71:66-70.
33. Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Echoes from the past and the periareolar blue method. Ann Surg 2000;232(1):81-89.
34. Nakamura Y, Yasuoka H, Tsujimoto M, et al. Lymph vessel density correlates with nodal status, VEGF-C expression, andprognosis in breast cancer. Breast Cancer Res Treat 2006;91(2):125-132.
35. Kumar R, Jana S, Heiba SI, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med 2002;44(1):7-10.
36. Kumar R, Potenta S, Alavi A.. Sentinel lymph node biopsy in multifocal and multicentric breast cancer. J Am Coll Surg 2004;198(4):674-676.
37. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 2002;9(3):272-277.
38. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999;188:248-254.
39. Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 2005;16:383-388.
40. Kuehn T, Vogl FD, Helms G, et al. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 2004;30:252-259.
41. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel lymph node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98(9):599-609.
42. Schirrmeister H, Kotzerke J, Vogl F, et al. Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. Cancer Biother Radiopharm 2004;19(6):784-790.
43. Bergkvist L, Frisell J, Liljegren G, et al. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001;88:1644-1648.
44. Cserni G.. Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 2003;56:327-335.
45. Berger AV, Davis DW, Tellez C, et al. Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction. Cancer Res 2005;65(23):11185- 11192.
46. Tanis PJ, Nieweg OE, Olmos RAV, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001;192(3):399-409.
47. Dewar DJ, Newell B, Green MA, et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004;22:3345-3349.